The use of circulating rosette-forming cells as a guide to determination of ATG dose (dose-by-rosette)

Transplant Proc. 1978 Sep;10(3):627-31.

Authors

P E Byfield, C L Barth, J A Brodie, A B Cosimi, S G Dienst, A J Elberg, G L Elfring, M A Hardy, H Hayashi, S L Kountz, K R Lamborn, B E Loughman, A Sakai, P S Satoh, C M Zielinski, W J Wechter

PMID: 362648

No abstract available

MeSH terms

Antilymphocyte Serum / therapeutic use*
Dose-Response Relationship, Immunologic
Humans
Kidney Transplantation
Monitoring, Physiologic
Rosette Formation*
T-Lymphocytes / immunology*

Substances

Antilymphocyte Serum